Rachel Teitelbaum wrote:
>> Actually, in the papers they were taking tumor cells from the host,
> transfecting them with the constuct, and reinjecting them to hosts that
> were syngeneic, that had the same tumor. They got rejection for the
> reason described, they now could see the tumor as foreign, cause some
> cells had B7. Has this entered the realm of clinical trials?
I did not read all the threads, but you can find clinical trials
information from PDQ database available on National Cancer Institute web
page.
Soon Paik
NSABP Pathology
